Migraine polygenic risk score associates with efficacy of migraine-specific drugs

Abstract

The migraine PRS can significantly identify subgroups of patients with a higher-than-average likelihood of a positive response to triptans, which provides a first step toward genetics-based precision medicine in migraine.